Journey Medical
DERMDERM · Stock Price
Historical price data
Overview
Journey Medical Corporation is a commercial-stage dermatology company with a mission to improve patient well-being by providing effective solutions for treating skin conditions. Its core strategy involves identifying, acquiring, and strategically commercializing innovative, differentiated dermatology products through a lean, experienced commercial team. As a publicly traded subsidiary of Fortress Biotech, the company has built a portfolio of approved products and employs an asset-light, acquisition-driven model to grow within the specialty dermatology market.
Technology Platform
Journey Medical's platform is its integrated commercial and operational model, consisting of a lean, experienced dermatology-focused team, a targeted sales force, and expertise in managed care, trade, and marketing to rapidly integrate and optimize acquired products.
Pipeline
7| Drug | Indication | Stage | Watch |
|---|---|---|---|
| glycopyrronium Topical Wipes | Hyperhidrosis | Phase 3 | |
| Glycopyrronium Topical Wipes | Hyperhidrosis | Phase 3 | |
| glycopyrronium Topical Wipes | Hyperhidrosis | Phase 3 | |
| Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate... | Hyperhidrosis | Phase 2 | |
| glycopyrrolate, 1.0% + glycopyrrolate, 2.0% + glycopyrrolate... | Hyperhidrosis | Phase 2 |
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Journey Medical competes with large pharma dermatology divisions, established dermatology biotechs, generic manufacturers, and other commercialization-focused firms. Its primary competitive advantages are its specialized commercial expertise, lean operational model, and focused relationships within the dermatology community.